Recreational Drugs Repurposed for Medicinal Use
-
Select format
-
- Publisher:
- Cambridge University Press
- Publication date:
- 24 July 2026
- 20 August 2026
- ISBN:
- 9781009585330
- 9781009585347
- Dimensions:
- Weight & Pages:
- Dimensions:
- (246 x 189 mm)
- Weight & Pages:
- 0.428kg, 192 Pages
You may already have access via personal or institutional login
Show more authors 
You may already have access via personal or institutional login
Book description
Recreational drugs that were once proscribed are now being explored as new pharmacotherapies. This topical book provides a balanced guide to new and far-reaching changes in our health system and our drug laws. Written by leading scientists, practitioners and researchers, it examines the evidence, discusses the history and context, and describes the pharmacology of recreational drugs that are being repurposed as medical treatments as well as recreational drugs that are currently being investigated. Amongst the drugs covered are psilocybin, cannabis, ketamine, MDMA, amphetamine and methylphenidate. Where known, the mechanisms of action, pharmacokinetics, putative indications, and safety and tolerability are described for each agent. Drugs used by indigenous communities for ritual purposes, currently being considered for treatment by the mainstream medical establishment, are also investigated. This is an up-to-date evidence-based resource for all people interested in the medical use of recreational drugs.
Contents
Metrics
Full text views
Full text views helpTotal number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...
* Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.
Usage data cannot currently be displayed.
Accessibility standard: WCAG 2.1 AA
Why this information is here
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.
Accessibility Information
The HTML of this book complies with version 2.1 of the Web Content Accessibility Guidelines (WCAG), covering newer accessibility requirements and improved user experiences and achieves the intermediate (AA) level of WCAG compliance, covering a wider range of accessibility requirements.
Content Navigation
Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
Reading Order and Textual Equivalents
Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
Short alternative textual descriptions
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
Full alternative textual descriptions
You get more than just short alt text: you have comprehensive text equivalents, transcripts, captions, or audio descriptions for substantial non‐text content, which is especially helpful for complex visuals or multimedia.
Visual Accessibility
Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
Structural and Technical Features
ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.